Kineta Inc (KA)
0.57
-0.06
(-8.80%)
USD |
NASDAQ |
May 10, 16:00
0.57
0.00 (0.00%)
After-Hours: 20:00
Kineta Cash from Financing (TTM): 8.468M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.468M |
September 30, 2023 | 14.81M |
June 30, 2023 | 16.25M |
Date | Value |
---|---|
March 31, 2023 | 14.07M |
December 31, 2022 | 11.81M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
8.468M
Minimum
Dec 2023
16.25M
Maximum
Jun 2023
13.08M
Average
14.07M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
Ironwood Pharmaceuticals Inc | 277.16M |
Ampio Pharmaceuticals Inc | 0.00 |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |